Immunomodulatory mechanisms of lactobacilli

Microbial Cell Factories

Volumn 10, Issue SUPPL. 1, 2011, Pages

  Wells, Jerry M ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN; CPG OLIGODEOXYNUCLEOTIDE; EXOPOLYSACCHARIDE; GAMMA INTERFERON; GENOMIC DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P70; LEUCINE RICH REPEAT KINASE 2; LIPOPROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; PATTERN RECOGNITION RECEPTOR; PEPTIDOGLYCAN; PROBIOTIC AGENT; RETINOIC ACID INDUCIBLE PROTEIN I; ROTAVIRUS VACCINE; THYMIC STROMAL LYMPHOPOIETIN; TOLL INTERLEUKIN 1 RECEPTOR DOMAIN CONTAINING ADAPTER INDUCING INTERFERON BETA; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VIRUS RNA; IMMUNOLOGIC FACTOR;

ADAPTIVE IMMUNITY; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL STRAIN; CD4+ T LYMPHOCYTE; CELL LINE; CELL STRUCTURE; CELLULAR DISTRIBUTION; CYTOKINE PRODUCTION; DENDRITIC CELL; DIMERIZATION; HOST PATHOGEN INTERACTION; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOGENICITY; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; INTESTINE EPITHELIUM; LACTOBACILLUS; LACTOBACILLUS CASEI; LACTOBACILLUS PLANTARUM; LAMINA PROPRIA; MACROPHAGE; MICROBE ASSOCIATED MOLECULAR PATTERN; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PARACRINE SIGNALING; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; SALIVA; SURVIVAL TIME; TH2 CELL; ANIMAL; EPITHELIUM CELL; IMMUNOLOGY; MOUSE; SIGNAL TRANSDUCTION;

BACTERIA (MICROORGANISMS); MUS;

ANIMALS; EPITHELIAL CELLS; HUMANS; IMMUNOLOGIC FACTORS; LACTOBACILLUS; MICE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TOLL-LIKE RECEPTORS;

EID: 80052258141     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/1475-2859-10-S1-S17     Document Type: Article

References (122)

1. Claesson MJ, van Sinderen D, O'Toole PW. The genus Lactobacillus--a genomic basis for understanding its diversity. FEMS Microbiol Lett 2007, 269(1):22-28. 10.1111/j.1574-6968.2006.00596.x, 17343688.
2. Lebeer S, Vanderleyden J, De Keersmaecker SC. Genes and molecules of lactobacilli supporting probiotic action. Microbiol Mol Biol Rev 2008, 72(4):728-764. Table of Contents, 10.1128/MMBR.00017-08, 2593565, 19052326.
3. Mackie RI, Sghir A, Gaskins HR. Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr 1999, 69(5):1035S-1045S.
4. Falagas ME, Betsi GI, Athanasiou S. Probiotics for the treatment of women with bacterial vaginosis. Clin Microbiol Infect 2007, 13(7):657-664. 10.1111/j.1469-0691.2007.01688.x, 17633390.
5. Ligaarden SC, Axelsson L, Naterstad K, Lydersen S, Farup PG. A candidate probiotic with unfavourable effects in subjects with irritable bowel syndrome: a randomised controlled trial. BMC Gastroenterol 2010, 10:16. 10.1186/1471-230X-10-16, 2831047, 20144246.
6. Brouwer ML, Wolt-Plompen SA, Dubois AE, van der Heide S, Jansen DF, Hoijer MA, Kauffman HF, Duiverman EJ. No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. Clin Exp Allergy 2006, 36(7):899-906. 10.1111/j.1365-2222.2006.02513.x, 16839405.
7. Folster-Holst R, Muller F, Schnopp N, Abeck D, Kreiselmaier I, Lenz T, von Ruden U, Schrezenmeir J, Christophers E, Weichenthal M. Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis. Br J Dermatol 2006, 155(6):1256-1261. 10.1111/j.1365-2133.2006.07558.x, 17107398.
8. Gruber C, Wendt M, Sulser C, Lau S, Kulig M, Wahn U, Werfel T, Niggemann B. Randomized, placebo-controlled trial of Lactobacillus rhamnosus GG as treatment of atopic dermatitis in infancy. Allergy 2007, 62(11):1270-1276. 10.1111/j.1398-9995.2007.01543.x, 17919141.
9. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997, 99(2):179-185. 10.1016/S0091-6749(97)70093-9, 9042042.
10. Sazawal S, Hiremath G, Dhingra U, Malik P, Deb S, Black RE. Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis 2006, 6(6):374-382. 10.1016/S1473-3099(06)70495-9, 16728323.
11. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000, 30(11):1604-1610.
12. Viljanen M, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, Kuitunen M. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy 2005, 60(4):494-500. 10.1111/j.1398-9995.2004.00514.x, 15727582.
13. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001, 357(9262):1076-1079. 10.1016/S0140-6736(00)04259-8, 11297958.
14. Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003, 361(9372):1869-1871. 10.1016/S0140-6736(03)13490-3, 12788576.
15. Kalliomaki M, Antoine JM, Herz U, Rijkers GT, Wells JM, Mercenier A. Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of allergic diseases by probiotics. J Nutr 2010, 140(3):713S-721S. 10.3945/jn.109.113761, 20130079.
16. Vliagoftis H, Kouranos VD, Betsi GI, Falagas ME. Probiotics for the treatment of allergic rhinitis and asthma: systematic review of randomized controlled trials. Ann Allergy Asthma Immunol 2008, 101(6):570-579. 10.1016/S1081-1206(10)60219-0, 19119700.
17. Wells JM, Loonen LM, Karczewski JM. The role of innate signaling in the homeostasis of tolerance and immunity in the intestine. Int J Med Microbiol 2010, 300(1):41-48. 10.1016/j.ijmm.2009.08.008, 19783476.
18. Abreu MT. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol 2010, 10(2):131-144. 10.1038/nri2707, 20098461.
19. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010, 11(5):373-384. 10.1038/ni.1863, 20404851.
20. Janssens S, Beyaert R. A universal role for MyD88 in TLR/IL-1R-mediated signaling. Trends Biochem Sci 2002, 27(9):474-482. 10.1016/S0968-0004(02)02145-X, 12217523.
21. Rescigno M. Intestinal dendritic cells. Adv Immunol 2010, 107:109-138.
22. Kapsenberg ML. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 2003, 3(12):984-993. 10.1038/nri1246, 14647480.
23. Wells JM, Rossi O, Meijerink M, van Baarlen P. Epithelial crosstalk at the microbiota-mucosal interface. Proc Natl Acad Sci U S A 2011, 108(Suppl 1):4607-4614.
24. Furrie E, Macfarlane S, Thomson G, Macfarlane GT. Toll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria. Immunology 2005, 115(4):565-574. 10.1111/j.1365-2567.2005.02200.x, 1782176, 16011525.
25. Abreu MT, Arnold ET, Thomas LS, Gonsky R, Zhou Y, Hu B, Arditi M. TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. J Biol Chem 2002, 277(23):20431-20437. 10.1074/jbc.M110333200, 11923281.
26. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 2000, 68(12):7010-7017. 10.1128/IAI.68.12.7010-7017.2000, 97811, 11083826.
27. Chabot S, Wagner JS, Farrant S, Neutra MR. TLRs regulate the gatekeeping functions of the intestinal follicle-associated epithelium. J Immunol 2006, 176(7):4275-4283.
28. Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, Bleharski JR, Maitland M, Norgard MV, Plevy SE, Smale ST, et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 1999, 285(5428):732-736. 10.1126/science.285.5428.732, 10426995.
29. Aliprantis AO, Yang RB, Mark MR, Suggett S, Devaux B, Radolf JD, Klimpel GR, Godowski P, Zychlinsky A. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 1999, 285(5428):736-739. 10.1126/science.285.5428.736, 10426996.
30. Hutchings MI, Palmer T, Harrington DJ, Sutcliffe IC. Lipoprotein biogenesis in Gram-positive bacteria: knowing when to hold 'em, knowing when to fold 'em. Trends Microbiol 2009, 17(1):13-21. 10.1016/j.tim.2008.10.001, 19059780.
31. Takeuchi O, Sato S, Horiuchi T, Hoshino K, Takeda K, Dong Z, Modlin RL, Akira S. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 2002, 169(1):10-14.
32. Jin MS, Kim SE, Heo JY, Lee ME, Kim HM, Paik SG, Lee H, Lee JO. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 2007, 130(6):1071-1082. 10.1016/j.cell.2007.09.008, 17889651.
33. Kang JY, Nan X, Jin MS, Youn SJ, Ryu YH, Mah S, Han SH, Lee H, Paik SG, Lee JO. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity 2009, 31(6):873-884. 10.1016/j.immuni.2009.09.018, 19931471.
34. Hermann C, Spreitzer I, Schroder NW, Morath S, Lehner MD, Fischer W, Schutt C, Schumann RR, Hartung T. Cytokine induction by purified lipoteichoic acids from various bacterial species--role of LBP, sCD14, CD14 and failure to induce IL-12 and subsequent IFN-gamma release. Eur J Immunol 2002, 32(2):541-551. 10.1002/1521-4141(200202)32:2<541::AID-IMMU541>3.0.CO;2-P, 11828371.
35. Hoebe K, Georgel P, Rutschmann S, Du X, Mudd S, Crozat K, Sovath S, Shamel L, Hartung T, Zahringer U, et al. CD36 is a sensor of diacylglycerides. Nature 2005, 433(7025):523-527. 10.1038/nature03253, 15690042.
36. Dunne DW, Resnick D, Greenberg J, Krieger M, Joiner KA. The type I macrophage scavenger receptor binds to gram-positive bacteria and recognizes lipoteichoic acid. Proc Natl Acad Sci U S A 1994, 91(5):1863-1867. 10.1073/pnas.91.5.1863, 43264, 8127896.
37. Grangette C, Nutten S, Palumbo E, Morath S, Hermann C, Dewulf J, Pot B, Hartung T, Hols P, Mercenier A. Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc Natl Acad Sci U S A 2005, 102(29):10321-10326. 10.1073/pnas.0504084102, 1177390, 15985548.
38. Deininger S, Figueroa-Perez I, Sigel S, Stadelmaier A, Schmidt RR, Hartung T, von Aulock S. Use of synthetic derivatives to determine the minimal active structure of cytokine-inducing lipoteichoic acid. Clin Vaccine Immunol 2007, 14(12):1629-1633. 10.1128/CVI.00007-07, 2168384, 17928431.
39. Perea Velez M, Verhoeven TL, Draing C, Von Aulock S, Pfitzenmaier M, Geyer A, Lambrichts I, Grangette C, Pot B, Vanderleyden J, et al. Functional analysis of D-alanylation of lipoteichoic acid in the probiotic strain Lactobacillus rhamnosus GG. Appl Environ Microbiol 2007, 73(11):3595-3604. 10.1128/AEM.02083-06, 1932685, 17434999.
40. Mohamadzadeh M, Pfeiler EA, Brown JB, Zadeh M, Gramarossa M, Managlia E, Bere P, Sarraj B, Khan MW, Pakanati KC, et al. Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc Natl Acad Sci U S A 2011, 108(Suppl 1):4623-4630.
41. Stacey KJ, Young GR, Clark F, Sester DP, Roberts TL, Naik S, Sweet MJ, Hume DA. The molecular basis for the lack of immunostimulatory activity of vertebrate DNA. J Immunol 2003, 170(7):3614-3620.
42. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408(6813):740-745. 10.1038/35047123, 11130078.
43. Lee J, Mo JH, Katakura K, Alkalay I, Rucker AN, Liu YT, Lee HK, Shen C, Cojocaru G, Shenouda S, et al. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol 2006, 8(12):1327-1336. 10.1038/ncb1500, 17128265.
44. Jijon H, Backer J, Diaz H, Yeung H, Thiel D, McKaigney C, De Simone C, Madsen K. DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology 2004, 126(5):1358-1373. 10.1053/j.gastro.2004.02.003, 15131797.
45. Ghadimi D, Vrese M, Heller KJ, Schrezenmeir J. Effect of natural commensal-origin DNA on toll-like receptor 9 (TLR9) signaling cascade, chemokine IL-8 expression, and barrier integritiy of polarized intestinal epithelial cells. Inflamm Bowel Dis 2010, 16(3):410-427.
46. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T, Endres S, Hartmann G. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002, 168(9):4531-4537.
47. Cowdery JS, Chace JH, Yi AK, Krieg AM. Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides. J Immunol 1996, 156(12):4570-4575.
48. Crabtree TD, Jin L, Raymond DP, Pelletier SJ, Houlgrave CW, Gleason TG, Pruett TL, Sawyer RG. Preexposure of murine macrophages to CpG oligonucleotide results in a biphasic tumor necrosis factor alpha response to subsequent lipopolysaccharide challenge. Infect Immun 2001, 69(4):2123-2129. 10.1128/IAI.69.4.2123-2129.2001, 98138, 11254566.
49. Obermeier F, Dunger N, Strauch UG, Grunwald N, Herfarth H, Scholmerich J, Falk W. Contrasting activity of cytosin-guanosin dinucleotide oligonucleotides in mice with experimental colitis. Clin Exp Immunol 2003, 134(2):217-224. 10.1046/j.1365-2249.2003.02288.x, 1808852, 14616780.
50. Rachmilewitz D, Karmeli F, Takabayashi K, Hayashi T, Leider-Trejo L, Lee J, Leoni LM, Raz E. Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology 2002, 122(5):1428-1441. 10.1053/gast.2002.32994, 11984528.
51. Obermeier F, Strauch UG, Dunger N, Grunwald N, Rath HC, Herfarth H, Scholmerich J, Falk W. In vivo CpG DNA/toll-like receptor 9 interaction induces regulatory properties in CD4+CD62L+ T cells which prevent intestinal inflammation in the SCID transfer model of colitis. Gut 2005, 54(10):1428-1436. 10.1136/gut.2004.046946, 1774700, 15879013.
52. Katakura K, Lee J, Rachmilewitz D, Li G, Eckmann L, Raz E. Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest 2005, 115(3):695-702. 1051992, 15765149.
53. Volz T, Nega M, Buschmann J, Kaesler S, Guenova E, Peschel A, Rocken M, Gotz F, Biedermann T. Natural Staphylococcus aureus-derived peptidoglycan fragments activate NOD2 and act as potent costimulators of the innate immune system exclusively in the presence of TLR signals. Faseb J 2010, 24(10):4089-4102. 10.1096/fj.09-151001, 20522786.
54. Ting JP, Willingham SB, Bergstralh DT. NLRs at the intersection of cell death and immunity. Nat Rev Immunol 2008, 8(5):372-379. 10.1038/nri2296, 18362948.
55. Girardin SE, Boneca IG, Carneiro LA, Antignac A, Jehanno M, Viala J, Tedin K, Taha MK, Labigne A, Zahringer U, et al. Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 2003, 300(5625):1584-1587. 10.1126/science.1084677, 12791997.
56. Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G, Philpott DJ, Sansonetti PJ. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003, 278(11):8869-8872. 10.1074/jbc.C200651200, 12527755.
57. Lala S, Ogura Y, Osborne C, Hor SY, Bromfield A, Davies S, Ogunbiyi O, Nunez G, Keshav S. Crohn's disease and the NOD2 gene: a role for paneth cells. Gastroenterology 2003, 125(1):47-57. 10.1016/S0016-5085(03)00661-9, 12851870.
58. Dalmasso G, Nguyen HT, Charrier-Hisamuddin L, Yan Y, Laroui H, Demoulin B, Sitaraman SV, Merlin D. PepT1 mediates transport of the proinflammatory bacterial tripeptide L-Ala-{gamma}-D-Glu-meso-DAP in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2010, 299(3):G687-696. 10.1152/ajpgi.00527.2009, 20558765.
59. Lee J, Tattoli I, Wojtal KA, Vavricka SR, Philpott DJ, Girardin SE. pH-dependent internalization of muramyl peptides from early endosomes enables Nod1 and Nod2 signaling. J Biol Chem 2009, 284(35):23818-23829. 10.1074/jbc.M109.033670, 2749154, 19570976.
60. Philpott DJ, Girardin SE. Nod-like receptors: sentinels at host membranes. Curr Opin Immunol 2010, 22(4):428-434. 10.1016/j.coi.2010.04.010, 20605429.
61. Billot-Klein D, Legrand R, Schoot B, van Heijenoort J, Gutmann L. Peptidoglycan structure of Lactobacillus casei, a species highly resistant to glycopeptide antibiotics. J Bacteriol 1997, 179(19):6208-6212. 179531, 9324275.
62. Delcour J, Ferain T, Deghorain M, Palumbo E, Hols P. The biosynthesis and functionality of the cell-wall of lactic acid bacteria. Antonie Van Leeuwenhoek 1999, 76(1-4):159-184.
63. Coyette J, Ghuysen JM. Structure of the walls of Lactobacillus acidophilus strain 63 AM Gasser. Biochemistry 1970, 9(15):2935-2943. 10.1021/bi00817a001, 4990834.
64. De Vuyst L, Degeest B. Heteropolysaccharides from lactic acid bacteria. FEMS Microbiol Rev 1999, 23(2):153-177.
65. Mobili P, Serradell Mde L, Trejo SA, Aviles Puigvert FX, Abraham AG, De Antoni GL. Heterogeneity of S-layer proteins from aggregating and non-aggregating Lactobacillus kefir strains. Antonie Van Leeuwenhoek 2009, 95(4):363-372. 10.1007/s10482-009-9322-y, 19306111.
66. Francius G, Lebeer S, Alsteens D, Wildling L, Gruber HJ, Hols P, De Keersmaecker S, Vanderleyden J, Dufrene YF. Detection, localization, and conformational analysis of single polysaccharide molecules on live bacteria. ACS Nano 2008, 2(9):1921-1929. 10.1021/nn800341b, 19206433.
67. Matsumoto S, Hara T, Hori T, Mitsuyama K, Nagaoka M, Tomiyasu N, Suzuki A, Sata M. Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells. Clin Exp Immunol 2005, 140(3):417-426. 10.1111/j.1365-2249.2005.02790.x, 1809392, 15932502.
68. Yasuda E, Serata M, Sako T. Suppressive effect on activation of macrophages by Lactobacillus casei strain Shirota genes determining the synthesis of cell wall-associated polysaccharides. Appl Environ Microbiol 2008, 74(15):4746-4755. 10.1128/AEM.00412-08, 2519339, 18552190.
69. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005, 122(1):107-118. 10.1016/j.cell.2005.05.007, 16009137.
70. Konstantinov SR, Smidt H, de Vos WM, Bruijns SC, Singh SK, Valence F, Molle D, Lortal S, Altermann E, Klaenhammer TR, et al. S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc Natl Acad Sci U S A 2008, 105(49):19474-19479. 10.1073/pnas.0810305105, 2592362, 19047644.
71. Pretzer G, Snel J, Molenaar D, Wiersma A, Bron PA, Lambert J, de Vos WM, van der Meer R, Smits MA, Kleerebezem M. Biodiversity-based identification and functional characterization of the mannose-specific adhesin of Lactobacillus plantarum. J Bacteriol 2005, 187(17):6128-6136. 10.1128/JB.187.17.6128-6136.2005, 1196140, 16109954.
72. Meijerink M, Wells JM. Probiotic modulation of dendritic cells and T cell responses in the intestine. Beneficial Microbes 2010, 1(4):317-216.
73. Foligne B, Nutten S, Grangette C, Dennin V, Goudercourt D, Poiret S, Dewulf J, Brassart D, Mercenier A, Pot B. Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World J Gastroenterol 2007, 13(2):236-243.
74. Zoumpopoulou G, Tsakalidou E, Dewulf J, Pot B, Grangette C. Differential crosstalk between epithelial cells, dendritic cells and bacteria in a co-culture model. Int J Food Microbiol 2009, 131(1):40-51. 10.1016/j.ijfoodmicro.2008.12.037, 19264370.
75. Peran L, Camuesco D, Comalada M, Nieto A, Concha A, Diaz-Ropero MP, Olivares M, Xaus J, Zarzuelo A, Galvez J. Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis. World J Gastroenterol 2005, 11(33):5185-5192.
76. Mileti E, Matteoli G, Iliev ID, Rescigno M. Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy. PLoS One 2009, 4(9):e7056. 10.1371/journal.pone.0007056, 2738944, 19756155.
77. Christensen HR, Frokiaer H, Pestka JJ. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 2002, 168(1):171-178.
78. van Hemert S, Meijerink M, Molenaar D, Bron PA, de Vos P, Kleerebezem M, Wells JM, Marco ML. Identification of Lactobacillus plantarum genes modulating the cytokine response of human peripheral blood mononuclear cells. BMC Microbiol 2010, 10:293. 10.1186/1471-2180-10-293, 3000848, 21080958.
79. Meijerink M, van Hemert S, Taverne N, Wels M, de Vos P, Bron PA, Savelkoul HF, van Bilsen J, Kleerebezem M, Wells JM. Identification of genetic loci in Lactobacillus plantarum that modulate the immune response of dendritic cells using comparative genome hybridization. PLoS One 2010, 5(5):e10632. 10.1371/journal.pone.0010632, 2869364, 20498715.
80. Vissers YM, Snel J, Zuurendonk PF, Smit BA, Wichers HJ, Savelkoul HF. Differential effects of Lactobacillus acidophilus and Lactobacillus plantarum strains on cytokine induction in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol 2010, 59(1):60-70. 10.1111/j.1574-695X.2010.00662.x, 20337702.
81. Miettinen M, Matikainen S, Vuopio-Varkila J, Pirhonen J, Varkila K, Kurimoto M, Julkunen I. Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells. Infect Immun 1998, 66(12):6058-6062. 108774, 9826398.
82. Miettinen M, Vuopio-Varkila J, Varkila K. Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect Immun 1996, 64(12):5403-5405. 174537, 8945595.
83. Niers LE, Hoekstra MO, Timmerman HM, van Uden NO, de Graaf PM, Smits HH, Kimpen JL, Rijkers GT. Selection of probiotic bacteria for prevention of allergic diseases: immunomodulation of neonatal dendritic cells. Clin Exp Immunol 2007, 149(2):344-352. 10.1111/j.1365-2249.2007.03421.x, 1941957, 17521319.
84. Latvala S, Pietila TE, Veckman V, Kekkonen RA, Tynkkynen S, Korpela R, Julkunen I. Potentially probiotic bacteria induce efficient maturation but differential cytokine production in human monocyte-derived dendritic cells. World J Gastroenterol 2008, 14(36):5570-5583. discussion 5581-5572, 10.3748/wjg.14.5570, 2746346, 18810777.
85. Kwon HK, Lee CG, So JS, Chae CS, Hwang JS, Sahoo A, Nam JH, Rhee JH, Hwang KC, Im SH. Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc Natl Acad Sci U S A 2010, 107(5):2159-2164. 10.1073/pnas.0904055107, 2836639, 20080669.
86. Denou E, Pridmore RD, Berger B, Panoff JM, Arigoni F, Brussow H. Identification of genes associated with the long-gut-persistence phenotype of the probiotic Lactobacillus johnsonii strain NCC533 using a combination of genomics and transcriptome analysis. J Bacteriol 2008, 190(9):3161-3168. 10.1128/JB.01637-07, 2347406, 18223069.
87. Marco ML, Peters TH, Bongers RS, Molenaar D, van Hemert S, Sonnenburg JL, Gordon JI, Kleerebezem M. Lifestyle of Lactobacillus plantarum in the mouse caecum. Environ Microbiol 2009, 11(10):2747-2757. 10.1111/j.1462-2920.2009.02001.x, 2978903, 19638173.
88. Lakhdari O, Cultrone A, Tap J, Gloux K, Bernard F, Ehrlich SD, Lefevre F, Dore J, Blottiere HM. Functional metagenomics: a high throughput screening method to decipher microbiota-driven NF-kappaB modulation in the human gut. PLoS One 2010, 5(9).
89. Fero M, Pogliano K. Automated quantitative live cell fluorescence microscopy. Cold Spring Harb Perspect Biol 2010, 2(8):a000455. 10.1101/cshperspect.a000455, 20591990.
90. Coombes JL, Maloy KJ. Control of intestinal homeostasis by regulatory T cells and dendritic cells. Semin Immunol 2007, 19(2):116-126. 10.1016/j.smim.2007.01.001, 17320411.
91. Bogunovic M, Ginhoux F, Helft J, Shang L, Hashimoto D, Greter M, Liu K, Jakubzick C, Ingersoll MA, Leboeuf M, et al. Origin of the lamina propria dendritic cell network. Immunity 2009, 31(3):513-525. 10.1016/j.immuni.2009.08.010, 2778256, 19733489.
92. Varol C, Vallon-Eberhard A, Elinav E, Aychek T, Shapira Y, Luche H, Fehling HJ, Hardt WD, Shakhar G, Jung S. Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity 2009, 31(3):502-512. 10.1016/j.immuni.2009.06.025, 19733097.
93. Rimoldi M, Chieppa M, Salucci V, Avogadri F, Sonzogni A, Sampietro GM, Nespoli A, Viale G, Allavena P, Rescigno M. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat Immunol 2005, 6(5):507-514. 10.1038/ni1192, 15821737.
94. Iliev ID, Mileti E, Matteoli G, Chieppa M, Rescigno M. Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning. Mucosal Immunol 2009, 2(4):340-350. 10.1038/mi.2009.13, 19387433.
95. Munn DH, Mellor AL. Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J Clin Invest 2007, 117(5):1147-1154. 10.1172/JCI31178, 1857253, 17476344.
96. Atuma C, Strugala V, Allen A, Holm L. The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. Am J Physiol Gastrointest Liver Physiol 2001, 280(5):G922-929.
97. Johansson ME, Phillipson M, Petersson J, Velcich A, Holm L, Hansson GC. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci U S A 2008, 105(39):15064-15069. 10.1073/pnas.0803124105, 2567493, 18806221.
98. Troost FJ, van Baarlen P, Lindsey P, Kodde A, de Vos WM, Kleerebezem M, Brummer RJ. Identification of the transcriptional response of human intestinal mucosa to Lactobacillus plantarum WCFS1 in vivo. BMC Genomics 2008, 9:374. 10.1186/1471-2164-9-374, 2519092, 18681965.
99. van Baarlen P, Troost FJ, van Hemert S, van der Meer C, de Vos WM, de Groot PJ, Hooiveld GJ, Brummer RJ, Kleerebezem M. Differential NF-kappaB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. Proc Natl Acad Sci U S A 2009, 106(7):2371-2376. 10.1073/pnas.0809919106, 2650163, 19190178.
100. van Baarlen P, Troost F, van der Meer C, Hooiveld G, Boekschoten M, Brummer RJ, Kleerebezem M. Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways. Proc Natl Acad Sci U S A 2011, 108(Suppl 1):4562-4569.
101. Isolauri E, Joensuu J, Suomalainen H, Luomala M, Vesikari T. Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine 1995, 13(3):310-312. 10.1016/0264-410X(95)93319-5, 7631519.
102. de Vrese M, Rautenberg P, Laue C, Koopmans M, Herremans T, Schrezenmeir J. Probiotic bacteria stimulate virus-specific neutralizing antibodies following a booster polio vaccination. Eur J Nutr 2005, 44(7):406-413. 10.1007/s00394-004-0541-8, 15578195.
103. Paineau D, Carcano D, Leyer G, Darquy S, Alyanakian MA, Simoneau G, Bergmann JF, Brassart D, Bornet F, Ouwehand AC. Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized, controlled trial. FEMS Immunol Med Microbiol 2008, 53(1):107-113. 10.1111/j.1574-695X.2008.00413.x, 18422632.
104. Kobayashi N, Saito T, Uematsu T, Kishi K, Toba M, Kohda N, Suzuki T. Oral administration of heat-killed Lactobacillus pentosus strain b240 augments protection against influenza virus infection in mice. Int Immunopharmacol 2011, 11(2):199-203. 10.1016/j.intimp.2010.11.019, 21095259.
105. Kotani Y, Shinkai S, Okamatsu H, Toba M, Ogawa K, Yoshida H, Fukaya T, Fujiwara Y, Chaves PH, Kakumoto K, et al. Oral intake of Lactobacillus pentosus strain b240 accelerates salivary immunoglobulin A secretion in the elderly: A randomized, placebo-controlled, double-blind trial. Immun Ageing 2010, 7:11. 10.1186/1742-4933-7-11, 2936365, 20796295.
106. Wells JM, Mercenier A. Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat Rev Microbiol 2008, 6(5):349-362. 10.1038/nrmicro1840, 18345021.
107. Lykova EA, Vorob'ev AA, Bokovoi AG, Pobedinskaia IN, Gevondian VS, Gevondian NM, Mitrokhin SD, Minaev VI, Dzis NB, Makkaveeva LF, et al. [Disruption of microbiocenosis of the large intestine and the immune and interferon status in children with bacterial complications of acute viral infections of the respiratory tract and their correction by high doses of bifidumbacterin forte]. Antibiot Khimioter 2000, 45(10):22-27.
108. Davidson LE, Fiorino AM, Snydman DR, Hibberd PL. Lactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: a randomized double-blind placebo-controlled trial. Eur J Clin Nutr 2011, 65(4):501-507. 10.1038/ejcn.2010.289, 21285968.
109. Cario E, Gerken G, Podolsky DK. Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology 2004, 127(1):224-238. 10.1053/j.gastro.2004.04.015, 15236188.
110. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004, 118(2):229-241. 10.1016/j.cell.2004.07.002, 15260992.
111. Wells JM, Konstaninov S, Konings I, Karczewski J. Effects of probiotic and commensals on epithelial barrier function. International Journal of Probiotics and Prebiotics. International Journal of Probiotics and Prebiotics 2008, 3(3):127-132.
112. Ulluwishewa D, Anderson RC, McNabb WC, Moughan PJ, Wells JM, Roy NC. Regulation of Tight Junction Permeability by Intestinal Bacteria and Dietary Components. J Nutr 2011,
113. Qin H, Zhang Z, Hang X, Jiang Y. L. plantarum prevents enteroinvasive Escherichia coli-induced tight junction proteins changes in intestinal epithelial cells. BMC Microbiol 2009, 9:63. 10.1186/1471-2180-9-63, 2674056, 19331693.
114. Anderson RC, Cookson AL, McNabb WC, Park Z, McCann MJ, Kelly WJ, Roy NC. Lactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression levels of genes involved in tight junction formation. BMC Microbiol 2010, 10:316. 10.1186/1471-2180-10-316, 3004893, 21143932.
115. Mangell P, Nejdfors P, Wang M, Ahrne S, Westrom B, Thorlacius H, Jeppsson B. Lactobacillus plantarum 299v inhibits Escherichia coli-induced intestinal permeability. Dig Dis Sci 2002, 47(3):511-516. 10.1023/A:1017947531536, 11911334.
116. Resta-Lenert S, Barrett KE. Probiotics and commensals reverse TNF-alpha- and IFN-gamma-induced dysfunction in human intestinal epithelial cells. Gastroenterology 2006, 130(3):731-746. 10.1053/j.gastro.2005.12.015, 16530515.
117. Mao Y, Nobaek S, Kasravi B, Adawi D, Stenram U, Molin G, Jeppsson B. The effects of Lactobacillus strains and oat fiber on methotrexate-induced enterocolitis in rats. Gastroenterology 1996, 111(2):334-344. 10.1053/gast.1996.v111.pm8690198, 8690198.
118. White JS, Hoper M, Parks RW, Clements WD, Diamond T, Bengmark S. The probiotic bacterium Lactobacillus plantarum species 299 reduces intestinal permeability in experimental biliary obstruction. Lett Appl Microbiol 2006, 42(1):19-23. 10.1111/j.1472-765X.2005.01800.x, 16411914.
119. Karczewski J, Troost FJ, Konings I, Dekker J, Kleerebezem M, Brummer RJ, Wells JM. Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am J Physiol Gastrointest Liver Physiol 2010, 298(6):G851-859. 10.1152/ajpgi.00327.2009, 20224007.
120. Seth A, Yan F, Polk DB, Rao RK. Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 2008, 294(4):G1060-1069. 10.1152/ajpgi.00202.2007, 2653458, 18292183.
121. Shen L, Black ED, Witkowski ED, Lencer WI, Guerriero V, Schneeberger EE, Turner JR. Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure. J Cell Sci 2006, 119(Pt 10):2095-2106.
122. Neish AS, Gewirtz AT, Zeng H, Young AN, Hobert ME, Karmali V, Rao AS, Madara JL. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 2000, 289(5484):1560-1563. 10.1126/science.289.5484.1560, 10968793.